View all news

ModivCare Reports Second Quarter 2021 Financial Results

08.06.2021

ModivCare Inc. (the “Company” or “ModivCare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three and six months ended June 30, 2021.

Second Quarter 2021 Highlights:

  • Revenue of $474.4 million, a 68.1% increase as compared to $282.3 million in the second quarter of 2020
  • Income from continuing operations, net of tax, of $13.8 million or $0.97 per diluted common share
  • Adjusted EBITDA of $53.1 million, Adjusted Net Income of $30.2 million and Adjusted EPS of $2.13
  • Net cash provided by operating activities during the quarter of $169.1 million
  • Repurchases of common stock during the quarter of $24.6 million
  • Cash and cash equivalents of $290.9 million at June 30, 2021, with $500.0 million debt outstanding related to the Senior Unsecured Notes
  • Matrix, on a standalone basis, achieved net income of $0.3 million and Adjusted EBITDA of $23.1 million

Subsequent Events:

  • On July 26, 2021, ModivCare announced that the Company has signed a merger agreement to acquire CareFinders Total Care LLC (“CareFinders”)
  • On August 3, 2021, ModivCare announced that the Company has signed a purchase agreement to acquire VRI Intermediate Holdings, LLC (“VRI”), an industry-leading provider of remote patient monitoring (“RPM”) and medication management solutions
  • On August 5, 2021, ModivCare announced that the Company has entered into a national partnership with Uber Health, aimed at further strengthening our network of transportation providers

Daniel E. Greenleaf, President and Chief Executive Officer, said, “In the second quarter we made significant progress automating and modernizing our non-emergency medical transportation ("NEMT") business and remain on target to deliver an estimated $50 million of durable annualized cost savings by year-end. Moreover, with the May 2021 acquisition of the best-in-class ATMS provider, WellRyde, we accelerated our national ‘go digital’ effort and have established a gold standard technology platform for serving our payor partners and patients. Our personal care segment benefited from a full quarter contribution from Simplura Health Group, which we acquired in November 2020 and which has seamlessly folded into our organization, creating an excellent foundation for growth. ModivCare’s second quarter Adjusted EBITDA of $53.1 million was in line with our expectations despite reflecting the impact of increased trip volume in our NEMT segment and temporary labor bottlenecks in both of our segments due to the pandemic.”

Mr. Greenleaf continued, “ModivCare is at the forefront of a seismic shift to more equitably connect patients with care. Subsequent to quarter end, we announced two significant acquisitions that advance our strategy to be a holistic provider of supportive care solutions designed to address the social determinants of health, remove barriers to care for underserved patient populations, deliver better care in the home, enhance patient lives and health outcomes, and reduce healthcare costs. We continue to utilize our NEMT network as a critical conduit to drive access to the essential services we provide and look for opportunities to expand access to care, as demonstrated by our partnership with Uber Health. We are very optimistic our supportive care solutions will deliver substantial value for our payor partners, patients, and shareholders.”

Heath Sampson, Chief Financial Officer, added, “ModivCare maintains a strong financial position, with $290.9 million of cash and cash equivalents, as of June 30, 2021, and an undrawn $225 million revolver. The company has received a commitment for $400 million of debt financing from Deutsche Bank Securities Inc. and Jefferies LLC to facilitate the closing of its recently announced acquisitions. ModivCare expects to maintain a strong balance sheet and liquidity profile following the acquisitions of CareFinders Total Care LLC for $340 million and the acquisition of VRI for $315 million. These transactions are expected to close in the third quarter of 2021, and they are expected to be meaningfully accretive to ModivCare earnings and cash flow on a combined basis.”

Second Quarter 2021 Results

For the second quarter of 2021, the Company reported revenue of $474.4 million, an increase of 68.1% from $282.3 million in the second quarter of 2020.

Operating income was $27.6 million, or 5.8% of revenue, in the second quarter of 2021, compared to operating income of $48.8 million, or 17.3% of revenue, in the second quarter of 2020. Income from continuing operations, net of tax, in the second quarter of 2021 was $13.8 million, or $0.97 per diluted common share, compared to income from continuing operations, net of tax, of $37.3 million, or a loss of $0.96 per diluted common share due to the preferred stock conversion, in the second quarter of 2020.

Adjusted EBITDA was $53.1 million, or 11.2% of revenue, in the second quarter of 2021, compared to $61.7 million, or 21.8% of revenue, in the second quarter of 2020.

Adjusted Net Income in the second quarter of 2021 was $30.2 million, or $2.13 per diluted common share, compared to $38.4 million, or $2.93 per diluted common share, in the second quarter of 2020.

Comparable Adjusted EBITDA and Adjusted Net Income for Q2 2020 were recast to show the impact of stock-based compensation and cash settled equity, which the Company is now excluding for purposes of these calculations.

The quarter-over-quarter increase in revenue was primarily due to incremental revenue of $109.7 million and $37.2 million associated with the acquisitions of Simplura and National MedTrans, respectively. Revenue further increased as a result of higher trip volume in our NEMT business, as the second quarter of the prior year was more heavily impacted by the COVID-19 pandemic.

Adjusted EBITDA decreased in the second quarter of 2021 due to higher service expense costs associated with higher utilization and contact center activity. Adjusted EBITDA also decreased as a result of higher corporate general and administrative cost as the Company continued to make investments in its employees and technology.

Matrix Medical Network

For the second quarter of 2021, Matrix’s revenue was $114.3 million, an increase of 26.1% from $90.7 million in the second quarter of 2020. Matrix had operating income of $4.5 million for the second quarter of 2021, compared to an operating income of $15.3 million for the second quarter of 2020.

ModivCare recorded income of $0.3 million related to its Matrix equity investment compared to an income of $4.4 million for the second quarter of 2020.

For the second quarter of 2021, Matrix recorded Adjusted EBITDA of $23.1 million or 20.2% of revenue, compared to $32.6 million, or 36.0% of revenue, for the second quarter of 2020.

Matrix’s Adjusted EBITDA for the second quarter of 2021 was negatively impacted by its Clinical Solutions business due to vaccination rollout in previous quarters and subsequent reduction in COVID testing, partially offset by the launch of the Clinical Trials business in October of 2020. Additionally, Matrix saw increased revenue and income related to a Clinical Solutions product offering following the October 2020 acquisition of Biocerna LLC, a diagnostic company that, among other things, provides rapid COVID-19 test kits, and is beginning to experience an increase in on-site visits in their risk adjustment business to pre-pandemic levels.

As of June 30, 2021, Matrix had $244.6 million in net debt and ModivCare's ownership interest was 43.6%.

Conference Call

ModivCare will hold a conference call to discuss its financial results on Friday, August 6, 2021 at 8:00 a.m. ET. To access the call, please dial:

US toll-free: 1 (877) 423 9820
International: 1 (201) 493 6749

You may also access the conference call via webcast at investors.modivcare.com, where the call also will be archived.

About ModivCare

ModivCare Inc. ("ModivCare") (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for public and private payors and their patients. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal and home care, and nutritional meal delivery. ModivCare also holds a minority equity interest in CCHN Group Holdings, Inc. and its subsidiaries ("Matrix Medical Network"), which partners with leading health plans and providers nationally, delivering a broad array of assessment and care management services to individuals that improve health outcomes and health plan financial performance. For more information, please visit us at www.modivcare.com.

Non-GAAP Financial Measures and Adjustments

In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), this press release includes EBITDA and Adjusted EBITDA for the Company and its segments, as well as Adjusted Net Income and Adjusted EPS for the Company, which are performance measures that are not recognized under GAAP. EBITDA is defined as income (loss) from continuing operations, net of taxes, before: (1) interest expense, net, (2) provision (benefit) for income taxes and (3) depreciation and amortization. Adjusted EBITDA is calculated as EBITDA before certain items, including (as applicable): (1) restructuring and related charges, including severance and office closure and professional services costs, (2) certain transaction and related costs, (3) cash settled equity, (4) stock-based compensation, (5) COVID-19 related costs, net of grant income, and (6) equity in net (income) loss of investee. Adjusted Net Income is defined as income from continuing operations, net of taxes, before certain items, including (1) restructuring and related charges including severance and office closure and professional services costs, (2) certain transaction and related costs, (3) cash settled equity, (4) stock-based compensation, (5) equity in net (income) loss of investee,(6) intangible amortization expense, (7) COVID-19 related costs, net of grant income, (8) tax impacts from the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"), and (9) the income tax impact of such adjustments. Adjusted EPS is calculated as Adjusted Net Income less (as applicable): (1) dividends on convertible preferred stock and (2) income allocated to participating securities, divided by the diluted weighted-average number of common shares outstanding as calculated for Adjusted Net Income. Our non-GAAP performance measures exclude certain expenses and amounts that are not driven by our core operating results and may be one time in nature. Excluding these expenses makes comparisons with prior periods as well as to other companies in our industry more meaningful. We believe such measures allow investors to gain a better understanding of the factors and trends affecting the ongoing operations of our business. We consider our core operations to be the ongoing activities to provide services from which we earn revenue, including direct operating costs and indirect costs to support these activities. In addition, our net income or loss in equity investee is excluded from these measures, as we do not have the ability to manage the venture, allocate resources within the venture, or directly control its operations or performance.

Our non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in our industry may calculate non-GAAP financial measures differently. In addition, there are limitations in using non-GAAP financial measures because they are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies, and exclude expenses that may have a material impact on our reported financial results. The presentation of non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the most directly comparable financial measures prepared in accordance with GAAP. We urge you to review the reconciliations of our non-GAAP financial measures to the most directly comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate our business.

Forward-Looking Statements

Certain statements contained in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as “may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend,” and similar words indicating possible future expectations, events or actions. Such forward-looking statements are based on current expectations, assumptions, estimates and projections about our business and our industry, and are not guarantees of our future performance. These statements are subject to a number of known and unknown risks, uncertainties and other factors, many of which are beyond our ability to control or predict, which may cause actual events to be materially different from those expressed or implied herein, including but not limited to: government or private insurance program funding reductions or limitations; alternative payment models or the transition of Medicaid and Medicare beneficiaries to Managed Care Organizations, or MCOs; our inability to control reimbursement rates received for our services; cost containment initiatives undertaken by private third-party payors; the effects of a public health emergency; inadequacies in, or security breaches of, our information technology systems, including the systems intended to protect our clients’ privacy and confidential information; any changes in the funding, financial viability or our relationships with our payors; pandemic infectious diseases, including the COVID-19 pandemic; disruptions to our contact center operations caused by health epidemics or pandemics like COVID-19; delays in collection, or non-collection, of our accounts receivable, particularly during any business integration; an impairment of our long-lived assets; any failure to maintain or to develop further reliable, efficient and secure information technology systems; an inability to attract and retain qualified employees; any acquisition or acquisition integration efforts; our contracts not surviving until the end of their stated terms, or not being renewed or extended; our failure to compete effectively in the marketplace; our not being awarded contracts through the government’s requests for proposals process, or our awarded contracts not being profitable; any failure to satisfy our contractual obligations or to maintain existing pledged performance and payment bonds; a failure to estimate accurately the cost of performing our contracts; any misclassification of the drivers we engage as independent contractors rather than as employees; significant interruptions in our communication and data services; not successfully executing on our strategies in the face of our competition; any inability to maintain relationships with existing patient referral sources; any failure to obtain the consent of the New York Department of Health to manage the day to day operations of our licensed in-home personal care services agency business that we acquired with our Personal Care Segment; acquired unknown liabilities in connection with the acquisition of our Personal Care Segment; changes in the case-mix of our personal care patients, or changes in payor mix or payment methodologies; our loss of existing favorable managed care contracts; our experiencing shortages in qualified employees and management; labor disputes or disruptions, in particular in New York; becoming subject to malpractice or other similar claims; and our reliance on our Matrix Investment segment's financial condition.

The Company has provided additional information about the risks facing our business in our annual report on Form 10-K and subsequent filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made and are expressly qualified in their entirety by the cautionary statements set forth herein and in our filings with the Securities and Exchange Commission, which you should read in their entirety before making an investment decision with respect to our securities. We undertake no obligation to update or revise any forward-looking statements contained in this release, whether as a result of new information, future events or otherwise, except as required by applicable law.

--financial tables to follow--

ModivCare Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

 

Service revenue, net

 

$

474,448

 

 

$

282,256

 

 

$

928,058

 

 

$

649,547

 

Grant income

 

852

 

 

 

 

3,500

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Service expense

 

379,566

 

 

196,106

 

 

739,898

 

 

528,767

 

General and administrative expense

 

56,347

 

 

31,199

 

 

111,217

 

 

51,994

 

Depreciation and amortization

 

11,819

 

 

6,108

 

 

24,059

 

 

9,898

 

Total operating expenses

 

447,732

 

 

233,413

 

 

875,174

 

 

590,659

 

 

 

 

 

 

 

 

 

 

Operating income

 

27,568

 

 

48,843

 

 

56,384

 

 

58,888

 

 

 

 

 

 

 

 

 

 

Other expenses (income):

 

 

 

 

 

 

 

 

Interest expense, net

 

8,287

 

 

1,498

 

 

16,710

 

 

1,739

 

Equity in net income of investee

 

(267)

 

 

(4,425)

 

 

(4,770)

 

 

(1,875)

 

Income from continuing operations before income taxes

 

19,548

 

 

51,770

 

 

44,444

 

 

59,024

 

Provision for income taxes

 

5,791

 

 

14,471

 

 

11,807

 

 

5,425

 

Income from continuing operations, net of tax

 

13,757

 

 

37,299

 

 

32,637

 

 

53,599

 

Loss from discontinued operations, net of tax

 

(85)

 

 

(301)

 

 

(124)

 

 

(503)

 

Net income

 

$

13,672

 

 

$

36,998

 

 

$

32,513

 

 

$

53,096

 

 

 

 

 

 

 

 

 

 

Net income (loss) available to common stockholders

 

$

13,672

 

 

$

(12,819)

 

 

$

32,513

 

 

$

1,920

 

 

 

 

 

 

 

 

 

 

Basic earnings (loss) per common share:

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.98

 

 

$

(0.96)

 

 

$

2.31

 

 

$

0.19

 

Discontinued operations

 

(0.01)

 

 

(0.02)

 

 

(0.01)

 

 

(0.04)

 

Basic earnings (loss) per common share

 

$

0.97

 

 

$

(0.98)

 

 

$

2.30

 

 

$

0.15

 

 

 

 

 

 

 

 

 

 

Diluted earnings (loss) per common share:

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.97

 

 

$

(0.96)

 

 

$

2.28

 

 

$

0.19

 

Discontinued operations

 

(0.01)

 

 

(0.02)

 

 

(0.01)

 

 

(0.04)

 

Diluted earnings (loss) per common share

 

$

0.96

 

 

$

(0.98)

 

 

$

2.27

 

 

$

0.15

 

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding:

 

 

 

 

 

 

 

 

Basic

 

14,025,325

 

 

13,077,596

 

 

14,151,946

 

 

13,032,931

 

Diluted

 

14,175,594

 

 

13,077,596

 

 

14,329,794

 

 

13,059,699

 

ModivCare Inc.

Unaudited Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

 

 

 

 

June 30, 2021

 

December 31, 2020

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

290,909

 

 

$

183,281

 

Accounts receivable, net

 

226,973

 

 

197,943

 

Other current assets (1)

 

38,999

 

 

44,634

 

Current assets of discontinued operations (2)

 

141

 

 

758

 

Total current assets

 

557,022

 

 

426,616

 

Operating lease right-of-use assets

 

45,791

 

 

30,928

 

Property and equipment, net

 

30,268

 

 

27,544

 

Goodwill and intangible assets, net

 

775,772

 

 

790,579

 

Equity investment

 

141,163

 

 

137,466

 

Other assets

 

26,182

 

 

12,780

 

Total assets

 

$

1,576,198

 

 

$

1,425,913

 

 

 

 

 

 

Liabilities and stockholders' equity

Current liabilities:

 

 

 

 

Accounts payable

 

$

16,253

 

 

$

8,464

 

Accrued contract payables

 

296,717

 

 

101,705

 

Accrued expenses and other current liabilities

 

109,143

 

 

117,010

 

Accrued transportation costs

 

88,615

 

 

79,674

 

Current portion of operating lease liabilities

 

8,665

 

 

8,277

 

Other current liabilities (3)

 

8,328

 

 

7,650

 

Current liabilities of discontinued operations (2)

 

1,527

 

 

1,971

 

Total current liabilities

 

529,248

 

 

324,751

 

Long-term debt, net of deferred financing costs

 

487,430

 

 

485,980

 

Operating lease liabilities, less current portion

 

32,531

 

 

23,437

 

Long-term contracts payables

 

2,292

 

 

72,183

 

Other long-term liabilities (4)

 

115,440

 

 

107,951

 

Total liabilities

 

1,166,941

 

 

1,014,302

 

 

 

 

 

 

Stockholders' equity

 

409,257

 

 

411,611

 

Total liabilities and stockholders' equity

 

$

1,576,198

 

 

$

1,425,913

 

(1)

  Includes other receivables, prepaid expenses and other current assets, and short-term restricted cash.

(2)

  Includes assets or liabilities related to WD Services' former Saudi Arabian operation.

(3)

  Includes deferred revenue and self-funded insurance programs.

(4)

  Includes other long-term liabilities and deferred tax liabilities.

ModivCare Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

 

 

 

 

 

 

 

Six months ended June 30,

 

 

2021

 

2020

Operating activities

 

 

 

 

Net income

 

$

32,513

 

 

$

53,096

 

Depreciation and amortization

 

24,059

 

 

9,898

 

Stock-based compensation

 

2,659

 

 

1,772

 

Equity in net income of investee

 

(4,770)

 

 

(1,875)

 

Deferred income taxes

 

(2,843)

 

 

11,441

 

Reduction of right-of-use assets

 

7,341

 

 

4,373

 

Loss on disposal of assets

 

 

 

216

 

Other non-cash items (1)

 

(136)

 

 

2,365

 

Changes in working capital (2)

 

110,290

 

 

65,902

 

Net cash provided by operating activities

 

169,113

 

 

147,188

 

 

 

 

 

 

Investing activities

 

 

 

 

Purchase of property and equipment

 

(8,132)

 

 

(2,330)

 

Acquisition, net of cash acquired

 

(15,843)

 

 

(77,665)

 

Net cash used in investing activities

 

(23,975)

 

 

(79,995)

 

 

 

 

 

 

Financing activities

 

 

 

 

Proceeds from debt

 

 

 

162,000

 

Repayment of debt

 

 

 

(162,000)

 

Preferred stock redemption payment

 

 

 

(82,769)

 

Preferred stock dividends

 

 

 

(1,961)

 

Repurchase of common stock, for treasury

 

(39,040)

 

 

(10,186)

 

Proceeds from common stock issued pursuant to stock option exercise

 

2,335

 

 

11,329

 

Restricted stock surrendered for employee tax payment

 

(820)

 

 

(37)

 

Other financing activities

 

(41)

 

 

(154)

 

Net cash used in financing activities

 

(37,566)

 

 

(83,778)

 

 

 

 

 

 

Net change in cash, cash equivalents and restricted cash

 

107,572

 

 

(16,585)

 

Cash, cash equivalents and restricted cash at beginning of period

 

183,356

 

 

61,673

 

Cash, cash equivalents and restricted cash at end of period

 

$

290,928

 

 

$

45,088

 

(1)

  Includes provision for doubtful accounts and amortization of deferred financing costs and debt discount.

(2)

  Includes accounts receivable and other receivables, prepaid expenses and other assets, self-funded insurance programs, income tax refunds on sale of business, accrued contract payables, accounts payable and accrued expenses, accrued transportation costs, deferred revenue and other long-term liabilities.

ModivCare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

 

 

 

Three months ended June 30, 2021

 

 

NEMT

 

Personal
Care

 

Matrix
Investment

 

Total
Continuing
Operations

 

 

 

 

 

 

 

 

 

Service revenue, net

$

364,760

 

 

$

109,688

 

 

$

 

 

$

474,448

 

Grant income

 

 

852

 

 

 

 

852

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Service expense

292,657

 

 

86,909

 

 

 

 

379,566

 

General and administrative expense

41,621

 

 

14,726

 

 

 

 

56,347

 

Depreciation and amortization

6,935

 

 

4,884

 

 

 

 

11,819

 

Total operating expenses

341,213

 

 

106,519

 

 

 

 

447,732

 

 

 

 

 

 

 

 

 

 

Operating income

23,547

 

 

4,021

 

 

 

 

27,568

 

 

 

 

 

 

 

 

 

 

Other expenses (income):

 

 

 

 

 

 

 

Interest expense, net

8,287

 

 

 

 

 

 

8,287

 

Equity in net income of investee

 

 

 

 

(267)

 

 

(267)

 

Income from continuing

 

 

 

 

 

 

 

operations before income taxes

15,260

 

 

4,021

 

 

267

 

 

19,548

 

Provision for income taxes

4,631

 

 

1,074

 

 

86

 

 

5,791

 

Income from continuing operations, net of taxes

10,629

 

 

2,947

 

 

181

 

 

13,757

 

 

 

 

 

 

 

 

 

 

Interest expense, net

8,287

 

 

 

 

 

 

8,287

 

Provision for income taxes

4,631

 

 

1,074

 

 

86

 

 

5,791

 

Depreciation and amortization

6,935

 

 

4,884

 

 

 

 

11,819

 

 

 

 

 

 

 

 

 

 

EBITDA

30,482

 

 

8,905

 

 

267

 

 

39,654

 

 

 

 

 

 

 

 

 

 

Restructuring and related charges (1)

4,483

 

 

 

 

 

 

4,483

 

Transaction costs (2)

2,239

 

 

1,245

 

 

 

 

3,484

 

Cash settled equity

4,452

 

 

 

 

 

 

4,452

 

Stock-based compensation

1,340

 

 

76

 

 

 

 

1,416

 

COVID-19 related costs, net of grant income

113

 

 

(251)

 

 

 

 

(138)

 

Equity in net income of investee

 

 

 

 

(267)

 

 

(267)

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

43,109

 

 

$

9,975

 

 

$

 

 

$

53,084

 

(1)

  Restructuring and related charges include professional services costs of $3.5 million and severance and office closure costs of $1.0 million.

(2)

  Transaction costs include Circulation management incentive plan ("MIP") costs and certain transaction-related expenses.

ModivCare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

 

 

 

Three months ended June 30, 2020

 

 

NEMT

 

Matrix
Investment

 

Total
Continuing
Operations

 

 

 

 

 

 

 

Service revenue, net

$

282,256

 

 

$

 

 

$

282,256

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

Service expense

196,106

 

 

 

 

196,106

 

General and administrative expense

31,199

 

 

 

 

31,199

 

Depreciation and amortization

6,108

 

 

 

 

6,108

 

Total operating expenses

233,413

 

 

 

 

233,413

 

 

 

 

 

 

 

 

Operating income

48,843

 

 

 

 

48,843

 

 

 

 

 

 

 

 

Other expenses (income):

 

 

 

 

 

Interest expense, net

1,498

 

 

 

 

1,498

 

Equity in net income of investee

 

 

(4,425)

 

 

(4,425)

 

Income from continuing

 

 

 

 

 

operations before income taxes

47,345

 

 

4,425

 

 

51,770

 

Provision for income taxes

13,363

 

 

1,108

 

 

14,471

 

Income from continuing operations, net of taxes

33,982

 

 

3,317

 

 

37,299

 

 

 

 

 

 

 

 

Interest expense, net

1,498

 

 

 

 

1,498

 

Provision for income taxes

13,363

 

 

1,108

 

 

14,471

 

Depreciation and amortization

6,108

 

 

 

 

6,108

 

 

 

 

 

 

 

 

EBITDA

54,951

 

 

4,425

 

 

59,376

 

 

 

 

 

 

 

 

Restructuring and related charges (1)

986

 

 

 

 

986

 

Transaction costs (2)

266

 

 

 

 

266

 

Cash settled equity (3)

4,547

 

 

 

 

4,547

 

Stock-based compensation (3)

691

 

 

 

 

691

 

COVID-19 related costs

209

 

 

 

 

209

 

Equity in net income of investee

 

 

(4,425)

 

 

(4,425)

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

61,650

 

 

$

 

 

$

61,650

 

(1)

  Restructuring and related charges include severance and office closure costs of $0.5 million and professional services costs of $0.5 million.

(2)

  Transaction costs include Circulation management incentive plan ("MIP") costs and certain transaction-related expenses.

(3)

  Adjusted EBITDA for Q2 of 2020 was recast to show the impact of stock-based compensation and cash settled equity, which the Company is now including for purposes of this calculation.

ModivCare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

 

 

 

Six months ended June 30, 2021

 

 

NEMT

 

Personal
Care

 

Matrix
Investment

 

Total
Continuing
Operations

 

 

 

 

 

 

 

 

 

Service revenue, net

$

708,176

 

 

$

219,882

 

 

$

 

 

$

928,058

 

Grant income

 

 

3,500

 

 

 

 

3,500

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Service expense

565,072

 

 

174,826

 

 

 

 

739,898

 

General and administrative expense

81,587

 

 

29,630

 

 

 

 

111,217

 

Depreciation and amortization

14,248

 

 

9,811

 

 

 

 

24,059

 

Total operating expenses

660,907

 

 

214,267

 

 

 

 

875,174

 

 

 

 

 

 

 

 

 

 

Operating income

47,269

 

 

9,115

 

 

 

 

56,384

 

 

 

 

 

 

 

 

 

 

Other expenses (income):

 

 

 

 

 

 

 

Interest expense, net

16,710

 

 

 

 

 

 

16,710

 

Equity in net income of investee

 

 

 

 

(4,770)

 

 

(4,770)

 

Income from continuing

 

 

 

 

 

 

 

operations before income taxes

30,559

 

 

9,115

 

 

4,770

 

 

44,444

 

Provision for income taxes

7,958

 

 

2,501

 

 

1,348

 

 

11,807

 

Income from continuing operations, net of taxes

22,601

 

 

6,614

 

 

3,422

 

 

32,637

 

 

 

 

 

 

 

 

 

 

Interest expense, net

16,710

 

 

 

 

 

 

16,710

 

Provision for income taxes

7,958

 

 

2,501

 

 

1,348

 

 

11,807

 

Depreciation and amortization

14,248

 

 

9,811

 

 

 

 

24,059

 

 

 

 

 

 

 

 

 

 

EBITDA

61,517

 

 

18,926

 

 

4,770

 

 

85,213

 

 

 

 

 

 

 

 

 

 

Restructuring and related charges (1)

8,128

 

 

 

 

 

 

8,128

 

Transaction costs (2)

4,854

 

 

2,290

 

 

 

 

7,144

 

Cash settled equity

6,545

 

 

 

 

 

 

6,545

 

Stock-based compensation

2,489

 

 

76

 

 

 

 

2,565

 

COVID-19 related costs, net of grant income

453

 

 

(2,100)

 

 

 

 

(1,647)

 

Equity in net income of investee

 

 

 

 

(4,770)

 

 

(4,770)

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

83,986

 

 

$

19,192

 

 

$

 

 

$

103,178

 

(1)

  Restructuring and related charges include professional services costs of $6.4 million and severance and office closure costs of $1.7 million.

(2)

  Transaction costs include Circulation management incentive plan ("MIP") costs and certain transaction-related expenses.

ModivCare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

 

 

 

Six months ended June 30, 2020

 

 

NEMT

 

Matrix
Investment

 

Total
Continuing
Operations

 

 

 

 

 

 

 

Service revenue, net

$

649,547

 

 

$

 

 

$

649,547

 

Grant income

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

Service expense

528,767

 

 

 

 

528,767

 

General and administrative expense

51,994

 

 

 

 

51,994

 

Depreciation and amortization

9,898

 

 

 

 

9,898

 

Total operating expenses

590,659

 

 

 

 

590,659

 

 

 

 

 

 

 

 

Operating income

58,888

 

 

 

 

58,888

 

 

 

 

 

 

 

 

Other expenses (income):

 

 

 

 

 

Interest expense, net

1,739

 

 

 

 

1,739

 

Equity in net income of investee

 

 

(1,875)

 

 

(1,875)

 

Income from continuing

 

 

 

 

 

operations before income taxes

57,149

 

 

1,875

 

 

59,024

 

Provision for income taxes

4,955

 

 

470

 

 

5,425

 

Income from continuing operations, net of taxes

52,194

 

 

1,405

 

 

53,599

 

 

 

 

 

 

 

 

Interest expense, net

1,739

 

 

 

 

1,739

 

Provision for income taxes

4,955

 

 

470

 

 

5,425

 

Depreciation and amortization

9,898

 

 

 

 

9,898

 

 

 

 

 

 

 

 

EBITDA

68,786

 

 

1,875

 

 

70,661

 

 

 

 

 

 

 

 

Restructuring and related charges (1)

2,308

 

 

 

 

2,308

 

Transaction costs (2)

1,121

 

 

 

 

1,121

 

Cash settled equity (3)

3,996

 

 

 

 

3,996

 

Stock-based compensation (3)

1,695

 

 

 

 

1,695

 

COVID-19 related costs, net of grant income

231

 

 

 

 

231

 

Equity in net (income) loss of investee

 

 

(1,875)

 

 

(1,875)

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

78,137

 

 

$

 

 

$

78,137

 

(1)

  Restructuring and related charges include severance and office closure costs of $1.2 million and professional services of $1.1 million.

(2)

  Transaction costs include Circulation MIP and certain transaction-related expenses.

(3)

  Adjusted EBITDA for the six months ended June 30, 2020 was recast to show the impact of stock-based compensation and cash settled equity, which the Company is now including for purposes of this calculation.

ModivCare Inc.

Unaudited Summary Financial Information of Equity Investment in Matrix Medical Network (1)

(in thousands)

 

 

Three months ended June 30,

 

Six months ended June 30,

 

2021

 

2020

 

2021

 

2020

Revenue

$

114,333

 

 

$

90,667

 

 

$

238,372

 

 

$

151,971

 

Operating expense

101,654

 

 

65,661

 

 

201,639

 

 

118,710

 

Depreciation and amortization

8,130

 

 

9,748

 

 

16,576

 

 

19,676

 

Operating income

4,549

 

 

15,258

 

 

20,157

 

 

13,585

 

 

 

 

 

 

 

 

 

Interest expense, net

4,088

 

 

4,989

 

 

8,166

 

 

10,719

 

Provision for income taxes

143

 

 

1,377

 

 

3,507

 

 

331

 

Net income

318

 

 

8,892

 

 

8,484

 

 

2,535

 

 

 

 

 

 

 

 

 

Equity Interest

43.6

%

 

43.6

%

 

43.6

%

 

43.6

%

Net income - Equity Investment

139

 

 

3,876

 

 

3,699

 

 

1,105

 

Management fee and other

128

 

 

549

 

 

1,071

 

 

770

 

Equity in net income of investee

$

267

 

 

$

4,425

 

 

$

4,770

 

 

$

1,875

 

 

 

 

 

 

 

 

 

Cash

$

75,490

 

 

$

39,006

 

 

 

 

 

Net Debt (2)

$

244,610

 

 

$

285,219

 

 

 

 

 

(1)

  The results of our equity method investment are excluded from the calculation of ModivCare's Adjusted EBITDA and Adjusted Net Income.

(2)

  Net debt represents long-term debt including the current portion, excluding deferred financing costs, less cash.

ModivCare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Adjusted EBITDA: Matrix Medical Network (1)

(in thousands)

 

 

Three months ended June 30,

 

Six months ended June 30,

 

2021

 

2020

 

2021

 

2020

Revenue

$

114,333

 

 

$

90,667

 

 

$

238,372

 

 

$

151,971

 

Operating expense

101,654

 

 

65,661

 

 

201,639

 

 

118,710

 

Depreciation and amortization

8,130

 

 

9,748

 

 

16,576

 

 

19,676

 

Operating income

4,549

 

 

15,258

 

 

20,157

 

 

13,585

 

 

 

 

 

 

 

 

 

Interest expense, net

4,088

 

 

4,989

 

 

8,166

 

 

10,719

 

Provision for income taxes

143

 

 

1,377

 

 

3,507

 

 

331

 

Net income

318

 

 

8,892

 

 

8,484

 

 

2,535

 

 

 

 

 

 

 

 

 

Depreciation and amortization

8,130

 

 

9,748

 

 

16,576

 

 

19,676

 

Interest expense

4,088

 

 

4,989

 

 

8,166

 

 

10,719

 

Provision for income taxes

143

 

 

1,377

 

 

3,507

 

 

331

 

EBITDA

12,679

 

 

25,006

 

 

36,733

 

 

33,261

 

Management fees

983

 

 

1,176

 

 

2,292

 

 

1,669

 

Integration costs

67

 

 

 

 

155

 

 

 

Severance costs

39

 

 

138

 

 

232

 

 

937

 

Restructuring expense

5,968

 

 

 

 

10,214

 

 

 

COVID-19 related costs

499

 

 

4,935

 

 

947

 

 

5,092

 

Transaction costs

2,897

 

 

1,369

 

 

4,422

 

 

1,754

 

Adjusted EBITDA

$

23,132

 

 

$

32,624

 

 

$

54,995

 

 

$

42,713

 

(1)

  ModivCare accounts for its proportionate share of Matrix's results using the equity method. Matrix's Adjusted EBITDA is not included within ModivCare's Adjusted EBITDA in any period presented.

ModivCare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Adjusted Net Income and Adjusted Net Income per Common Share:

(in thousands, except share and per share data)

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

 

Income from continuing operations, net of tax

$

13,757

 

 

$

37,299

 

 

$

32,637

 

 

$

53,599

 

 

 

 

 

 

 

 

 

Restructuring and related charges(1)

4,482

 

 

986

 

 

8,128

 

 

2,308

 

Transaction costs(2)

3,484

 

 

266

 

 

7,144

 

 

1,121

 

Cash settled equity(3)

4,452

 

 

4,547

 

 

6,545

 

 

3,996

 

Stock-based compensation(3)

1,416

 

 

691

 

 

2,565

 

 

1,695

 

Equity in net income of investee

(267)

 

 

(4,425)

 

 

(4,770)

 

 

(1,875)

 

Intangible amortization expense

9,148

 

 

3,775

 

 

18,649

 

 

5,334

 

COVID-19 related costs, net of grant income

(138)

 

 

209

 

 

(1,647)

 

 

231

 

Tax impact of the CARES Act

 

 

76

 

 

 

 

(10,984)

 

Tax effected impact of adjustments

(6,100)

 

 

(167)

 

 

(10,012)

 

 

(1,831)

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income

$

30,234

 

 

$

43,257

 

 

$

59,239

 

 

$

53,594

 

 

 

 

 

 

 

 

 

 

Dividends on convertible preferred stock

 

 

(866)

 

 

 

 

(1,961)

 

Income allocated to participating securities

 

 

(4,024)

 

 

 

 

(5,560)

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income available to common stockholders

$

30,234

 

 

$

38,367

 

 

$

59,239

 

 

$

46,073

 

 

 

 

 

 

 

 

 

 

Adjusted earnings per share

$

2.13

 

 

$

2.93

 

 

$

4.13

 

 

$

3.53

 

 

 

 

 

 

 

 

 

 

Diluted weighted-average number of common shares outstanding

14,175,594

 

 

13,077,596

 

 

14,329,794

 

 

13,059,699

 

(1)

  Restructuring and related charges include severance and office closure costs and professional services.

(2)

  Transaction costs include the MIP related to the Circulation acquisition and certain other transaction-related expenses.

(3)

  Adjusted net income for the three and six months ended June 30, 2020 was recast to show the impact of stock-based compensation and cash settled equity, which the Company is now excluding for purposes of this calculation.

 

Investor Relations Contact
Kalle Ahl, The Equity Group
(212) 836-9614
kahl@equityny.com

Source: ModivCare Inc.

Multimedia Files:

View all news